What defines a pulmonary exacerbation? The perceptions of adults with cystic fibrosis  by Abbott, J. et al.
S112 12. Nursing – Psychosocial issues
447 What deﬁnes a pulmonary exacerbation? The perceptions of
adults with cystic ﬁbrosis
J. Abbott1, A. Holt1, H.C. Rodgers2, A. Morton3, A. Hart1, L. MacDougall2,
M. Pogson2, G. Milne2, S.P. Conway3. 1Faculty of Health, University of Central
Lancashire, Preston, United Kingdom; 2Adult Cystic Fibrosis Unit, Ninewells
Hospital, Dundee, United Kingdom; 3Adult Cystic Fibrosis Unit, St James’
Hospital, Leeds, United Kingdom
Introduction: There is no standardised deﬁnition of a pulmonary exacerbation in
cystic ﬁbrosis (CF). As part of the process of achieving standardised criteria it is
important to identify patient-reported indicators.
Methods: Interviews were undertaken with adults with CF. They were asked
to report all symptoms experienced during a pulmonary exacerbation, the ﬁrst
symptoms they become aware of, and how they subsequently recognised when
they were improving. Purposive sampling ensured representation of key variables
including age, gender, in/out-patient, large/small CF unit, FEV1% predicted, BMI,
microbiology, number of clinically recorded exacerbations in past year, diabetes,
nutritional and transplant status. Interviews were taped, transcribed verbatim and
the data analysed thematically.
Results: A range of systemic and respiratory symptoms were reported. Their
relative importance varied by severity of disease. For many patients the onset of an
exacerbation was characterised by fatigue and changes in cough, sputum, sleep and
appetite. Those with mild disease typically reported ‘cold’ symptoms whereas those
with severe disease found it more difﬁcult to recognise the onset of an exacerbation.
The severity and subsequent improvement of an exacerbation was often described
in terms of limitations on their activities.
Conclusion: Patient-reported indicators of a pulmonary exacerbation may not be
the same for all adults with CF. Whether different indicators are associated with
speciﬁc demographic or clinical variables remains to be evaluated in ongoing work.
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